WASF2 and cancer: Currently, no ROCK inhibitor is used for clinical trials for treatment of cancer, but many ROCK inhibitors such as Y27632 [136] and Fasudil [137] have shown significant effects in both cancer cell lines and rodent cancer models, supporting the overall importance of ROCK-WAVE2 signaling in the development and progression of cancer.